| Case | Age | Parity | GA | Serum hCG (mIU/mL) | Primary treatment | Additional treatment | Follow-up period (days) |
| 1 | 29 | 1G1P | 7 | 93,892 | Laparoscopy | None | 51 |
| 2 | 31 | 1G1P | 6 | 34,165 | MTX | Laparoscopy | 42 |
| 3 | 29 | 1G1P | 6 | 28,892 | MTX | Laparotomy | 55 |
| 4 | 28 | 4G3P | 7 | 28,300 | MTX | None | 42 |
| 5 | 26 | 2G2P | 8 | 12,770 | MTX | None | 47 |
| 6 | 32 | 2G2P | 6 | 4970 | MTX | None | 41 |
| 7 | 37 | 5G2P | 4 | 6488 | MTX | None | 48 |
| 8 | 35 | 3G3P | 7 | 18,527 | Laparotomy | None | 36 |
| 9 | 36 | 1G1P | 10 | >100,000 | Laparotomy | None | 45 |
| 10 | 29 | 6G3P | 6 | 42,403 | Laparoscopy | None | 40 |
| 11 | 35 | 2G2P | 7 | 33,592 | Laparoscopy | None | 45 |